Should NASDAQ: AMTI Stock Be In Your Portfolio Or Not?



The NASDAQ: AMTI at is the trading symbol for the company Applied Molecular Transport, Inc. This is a biopharmaceutical clinical-stage company. The company has been leveraging its technology platform for the designing and development of a pipeline of biological product candidates for the treatment of inflammatory, autoimmune, metabolic, and some other diseases. Applied Molecular Transport has been building a portfolio of the oral product candidates that are based on the technology platform of the company including its product AMT-101. AMT101 is an oral GI-selective rhIL-10. It has completed its phase 1b clinical trials in ulcerative colitis (UC) patients. AMT-126 is the company’s other candidate. It’s a GI-selective fusion of rhIL-22. The technology platform of the company enables it to develop and design many oral therapeutic modalities, like proteins, peptides, antibody fragments, full-length antibodies, and RNA ribonucleic acid therapeutics, along with drugs of the development stage.

Applied Molecular Transport announced the pricing of Initial Price Offering

Applied Molecular Transport is offering all the shares of the common stock. Their shares are traded on the National Association of Securities Dealers Automated Quotations Global Select Market. It is traded under the symbol NASDAQ: AMTI. Further, Applied Molecular Transport granted underwriters an option of 30 days to purchase additional 1,650,000 common stock shares at the IPO price.

AMTI Stock

As of 1st July 2020, the stock was trading at the price of $25.21. It was at a rise of 0.07 US dollars or a 0.26% rise from the previous price of $25.14. The stock has been trading between the prices of $24.88 and $26.70 recently. The volume of the trade of this stock has been light nowadays. On 1st July 2020 till 9:56 AM, 20,519 shares of the stock had traded compared to the average trading volume of 763,052 shares.

Should the Applied Molecular Transport stock AMTI be there in your Portfolio?

The Applied Molecular Transport Stock, AMTI rose by 56.84% from 5th to 25th June when it began trading. The proprietary of the InvestorsObserver ranking system gave the AMTI stock a score of 0 out of 100. Over the past year, the stock has fallen about -1.18 US dollars per share.

Some more Headlines concerning Applied Molecular Transport

Applied Molecular Transport has been in the news lately. Some more headlines concerning the company are:

  • Biotech Applied Molecular Transport to offer 10 million shares in planned IPO, priced at $12 to $14 each
  •  Inflammatory disease biotech Applied Molecular Transport aims for $100M IPO
  • Applied Molecular Transport’s Proprietary Approach to Designing Oral Biologic Therapeutics Published in Tissue Barriers Journal

AMT stock has a 52 week peek range of 17.05 – 31.84 and it’s volume remains around 250,000 to 300,000. You can check more stock news at the paper trading app. Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Leave a Reply

Your email address will not be published. Required fields are marked *

Enter Captcha Here : *

Reload Image